← Back to Search

Attention Control Text Messaging for Alcohol Consumption (PASSION Trial)

N/A
Waitlist Available
Led By Dominic J Parrott, Ph.D.
Research Sponsored by Georgia State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up burst 3, daily for 14 days
Awards & highlights

Summary

This trial will study the effects of stress from the COVID-19 pandemic on heavy drinking and intimate partner violence in sexual and gender minority couples, and test a text messaging intervention to help mitigate these effects.

Eligible Conditions
  • Alcohol Consumption
  • Domestic Violence
  • Stress
  • Aggression

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~burst 2, daily for 14 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and burst 2, daily for 14 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Drinking Episodes (Burst 1)
Drinking Episodes (Burst 2)
Drinking Episodes (Burst 3)
+5 more
Secondary outcome measures
COVID-19 Stress (Burst 1)
COVID-19 Stress (Burst 2)
COVID-19 Stress (Burst 3)
+5 more

Trial Design

8Treatment groups
Experimental Treatment
Active Control
Group I: No Intervention, CBT Texts (AC)Experimental Treatment1 Intervention
Participants do not receive text messages during Interval 2. Participants receive CBT text messages during Interval 3.
Group II: CBT Texts, No Intervention (CA)Experimental Treatment1 Intervention
Participants receive CBT text messages during Interval 2. Participants do not receive text messages during Interval 3.
Group III: CBT Texts, Attention-Control Texts (CB)Experimental Treatment2 Interventions
Participants receive CBT text messages during Interval 2. Participants receive attention control text messages during Interval 3.
Group IV: Attention-Control Texts, CBT Texts (BC)Experimental Treatment2 Interventions
Participants receive attention control text messages during Interval 2. Participants receive CBT text messages during Interval 3.
Group V: No Intervention, No Intervention (AA)Active Control1 Intervention
Participants do not receive text messages during Interval 2 or Interval 3.
Group VI: Attention-Control Texts, No Intervention (BA)Active Control1 Intervention
Participants receive attention control text messages during Interval 2. Participants do not receive text messages during Interval 3.
Group VII: No Intervention, Attention-Control Texts (AB)Active Control1 Intervention
Participants do not receive text messages during Interval 2. Participants receive attention control text messages during Interval 3.
Group VIII: Attention-Control Texts, Attention-Control Texts (BB)Active Control1 Intervention
Participants receive attention control text messages during Interval 2. Participants receive attention control text messages during Interval 3.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Attention Control Text Messaging
2020
N/A
~480
CBT Text Messaging
2020
N/A
~480

Find a Location

Who is running the clinical trial?

University of LouisvilleOTHER
340 Previous Clinical Trials
76,890 Total Patients Enrolled
University at BuffaloOTHER
132 Previous Clinical Trials
98,499 Total Patients Enrolled
Georgia State UniversityLead Sponsor
60 Previous Clinical Trials
28,663 Total Patients Enrolled

Media Library

Attention Control Text Messaging Clinical Trial Eligibility Overview. Trial Name: NCT04625465 — N/A
Alcohol Consumption Research Study Groups: No Intervention, No Intervention (AA), No Intervention, CBT Texts (AC), CBT Texts, No Intervention (CA), Attention-Control Texts, No Intervention (BA), No Intervention, Attention-Control Texts (AB), Attention-Control Texts, Attention-Control Texts (BB), Attention-Control Texts, CBT Texts (BC), CBT Texts, Attention-Control Texts (CB)
Alcohol Consumption Clinical Trial 2023: Attention Control Text Messaging Highlights & Side Effects. Trial Name: NCT04625465 — N/A
Attention Control Text Messaging 2023 Treatment Timeline for Medical Study. Trial Name: NCT04625465 — N/A
~103 spots leftby Jul 2025